European Archives - Page 477 of 1104 - European Medical Journal

Sanofi to adopt “race-like mindset” with F1 collab

Sanofi and McLaren Racing join forces to improve drug manufacturing efficiency and R&D. Read now for more details.

High Opioid Use Before Total Knee Arthroplasty

Insights into high rates of opioid use, specifically in patients with osteoarthritis (OA) before undergoing total knee arthroplasty…

Imaging Shows Importance of Weight Change in Knee Osteoarthritis

Which showed that weight gain could worsen the damage of knee OA, as demonstrated through biomedical imaging…

Can You Trust Your Gut?

Johnathan and Dr Oliver Grundmann discuss their opinions on the use of vitamins, and how the gut microbiota and central nervous system are connected.

Social Impacts and Quality of Life in Patients with β-Thalassaemia

My selection for this issue is the article ‘Social Impact and Quality of Life of Patients with β-Thalassemia: A Systematic Review’ by Greco and Marino. Quality of life is becoming more and more important in the evaluation of clinical trials, and also by regulatory authorities, particularly in chronic diseases (which can be seen by the U.S. Food and Drug Administration’s [FDA] recent position on luspatercept). Therefore, understanding its meaning and limitations is very important.

Clinical Challenges and Limitations in β-Thalassaemia Treatment and Their Impact on Patient Outcomes

Cappellini shares her expert insights into β-thalassaemia with our chair, internationally renowned surgeon Jonathan Sackier. With a focus…

Can Ultrasound Imaging Assess Malignancy in Ovarian Cancer?

Novel study findings have highlighted how the appearance of ovarian lesions on ultrasound can be an effective predictor of cancer risk…

Increasing Efficiencies Through a Novel Approach to AI-Integrated Medical Imaging

Artificial imaging has been implemented into medical imaging to enhance the precision and reliability of diagnosis…

Pharma in South Africa

Exploring the pharmaceutical landscape in South Africa, GOLD considers several areas that are shaping the nation’s role in the future of global pharmaceuticals

Case Report of Epstein–Barr Virus-Induced Autoimmune Vitiligo in Nigeria

Vitiligo is an acquired skin depigmenting disorder resulting from melanocytes loss in the epidermis, associated with an autoimmune aetiopathophysiology. However, there are limited data about the association between vitiligo and Epstein–Barr virus (EBV).